Description:

North Central Cancer Treatment Group N0577 Pathology Submission Form Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C08FC47-BFC6-632C-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C08FC47-BFC6-632C-E044-0003BA3F9857

Keywords:

Brain Neoplasms

Central Nervous System Neoplasms

Uploaded on:

September 20, 2021

DOI:

To request one please log in.

License :

Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Brain and Central Nervous System Tumors NCT00887146 Pathology - North Central Cancer Treatment Group N0577 Pathology Submission Form - 2745984v1.0

No Instruction available.

StudyEvent: North Central Cancer Treatment Group N0577 Pathology Submission Form
1. No Instruction available.

Header

Protocol Number

Patient ID

Patient Initials (L F M)

Institution Number

Institution Name

Header

Date Specimen Shipped

Number of slides submitted

Accession Number

Accession Number

Number of blocks sent

Instructions

Contact Person at Institution (Institutional Contact Information:)

Comments

Street Address

City

Institution Name

State

Postal Code

Phone Number

Fax Number

Unnamed2

Comments

Back to the top of the page

Similar models

Show recommended models

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.